Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 35851-35900 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT06350994
Early Assessment of Cardiac Function After Treatment With CAR-T Cells
N/ARecruiting
60 participants
Started: Nov 7, 2024 · Completed: Mar 31, 2027
5 conditions1 sponsor1 location
NCT06662838
Ergonomics and First Aid Training for Children of Seasonal Agricultural Worker Families
NANot yet recruiting
140 participants
Started: Nov 7, 2024 · Completed: Dec 20, 2024
1 condition1 sponsor1 location
NCT06698614
MEMRI and Kidney Disease
N/ARecruiting
120 participants
Started: Nov 7, 2024 · Completed: Nov 7, 2029
4 conditions2 sponsors1 location
NCT06732310
The Unique and Combined Effects of Prenatal and Early Childhood Programming on Child Maltreatment: Examining Mechanisms of Change
PHASE2Enrolling by invitation
600 participants
Started: Nov 7, 2024 · Completed: Aug 31, 2029
4 conditions2 sponsors2 locations
NCT07093086
Clinical Study of Multi-targeted CAR-T Therapy in Patients With Relapsed/Refractory B-Cell Lymphoma
PHASE1Recruiting
20 participants
Started: Nov 7, 2024 · Completed: Dec 18, 2028
1 condition1 sponsor2 locations
NCT06677099
Electrical Impedance Tomography in Guiding Early and Precise Rehabilitation of Patients with Difficult Ventilator Weaning
NANot yet recruiting
80 participants
Started: Nov 7, 2024 · Completed: Dec 30, 2025
1 condition1 sponsor0 locations
NCT06700096
An Open-Label, Comparative Study of the Efficacy, Safety and Pharmacodynamics of Single Dose of ANB-002 in Patients With Hemophilia B
PHASE3Recruiting
24 participants
Started: Nov 7, 2024 · Completed: Mar 31, 2032
1 condition1 sponsor11 locations
NCT06493032
The Use of Body Surface Gastric Mapping in Assessing the Clinical Success of G-POEM
NARecruiting
20 participants
Started: Nov 7, 2024 · Completed: Jun 1, 2026
1 condition1 sponsor1 location
NCT06328751
Meditation With Virtual Reality for Cancer Pain Relief in the Pain Therapy and Palliative Care Service
NARecruiting
129 participants
Started: Nov 7, 2024 · Completed: Jan 31, 2027
3 conditions2 sponsors1 location
NCT06476665
A Study to Learn About the Safety of BESPONSA Injection in Pediatric Patients With Acute Lymphocytic Leukemia.
N/AActive, not recruiting
7 participants
Started: Nov 7, 2024 · Completed: Jun 22, 2029
1 condition1 sponsor1 location
NCT06674031
Knowledge of Cardiovascular Risk Factors in Chronic Kidney Disease Patients
N/ARecruiting
28 participants
Started: Nov 6, 2024 · Completed: May 31, 2025
2 conditions1 sponsor1 location
NCT06933420
Clinical Protocol CERN Feasibility Study
NARecruiting
9 participants
Started: Nov 6, 2024 · Completed: May 31, 2025
2 conditions1 sponsor3 locations
NCT06678334
Characteristic Transcriptomic, Proteomic and Metabolomic Molecular Studies of Nasal Secretions From Chronic Rhinitis
N/ANot yet recruiting
1,000 participants
Started: Nov 6, 2024 · Completed: Dec 1, 2032
1 condition1 sponsor0 locations
NCT06683222
Mediating Role of Myokines in the Dialogue Between Muscle and Bone Tissue in a Population of Healthy Women Aged 20-89 Years
NARecruiting
280 participants
Started: Nov 6, 2024 · Completed: Sep 30, 2029
1 condition1 sponsor2 locations
NCT06618300
Streamlined Resin Y90 Radiation Segmentectomy for Small HCC
N/AEnrolling by invitation
30 participants
Started: Nov 6, 2024 · Completed: Dec 31, 2027
1 condition2 sponsors1 location
NCT06652919
Survey on the Evaluation of Medication Information Leaflets for Organ Transplant Patients
N/ARecruiting
30 participants
Started: Nov 6, 2024 · Completed: Mar 31, 2025
1 condition1 sponsor1 location
NCT06311331
Prospective Evaluation of Clinical and Radiographic Outcomes Following Total Talus Replacement (PROCLAIM)
N/AEnrolling by invitation
50 participants
Started: Nov 6, 2024 · Completed: Nov 30, 2031
3 conditions2 sponsors1 location
NCT06641154
Gene Therapy for Crigler Najjar Syndrome Type I (AlphaCN)
PHASE1/PHASE2Recruiting
5 participants
Started: Nov 6, 2024 · Completed: Nov 1, 2029
1 condition1 sponsor2 locations
NCT06479239
Study of EGFRBi Armed Fresh PBMC in Metastatic or Unresectable Pancreatic Cancer
PHASE1/PHASE2Recruiting
23 participants
Started: Nov 6, 2024 · Completed: Jun 30, 2031
2 conditions1 sponsor1 location
NCT07031102
Methacholine Challenge Test in School Children With/Without Asthma RISKA
N/ARecruiting
260 participants
Started: Nov 6, 2024 · Completed: Dec 31, 2027
3 conditions1 sponsor1 location
NCT06690528
Conversion Surgery Vs. Palliative Care in Pancreatic Cancer Oligometastatic to the Liver
PHASE2Recruiting
56 participants
Started: Nov 6, 2024 · Completed: Nov 30, 2028
1 condition2 sponsors1 location
NCT06794489
Longitudinal Biomarkers with Selected Outcome Measures in CMT
N/ARecruiting
75 participants
Started: Nov 6, 2024 · Completed: Aug 5, 2025
4 conditions1 sponsor1 location
NCT06470919
The Next Generation Vaccine Card: Innovative Technology to Improve Vaccine Equity in Rural and Urban Settings in East Africa
NARecruiting
2,700 participants
Started: Nov 6, 2024 · Completed: Jan 31, 2026
1 condition2 sponsors2 locations
NCT06544408
Rapid Treatment of PTSD With Accelerated Non-Invasive Brain Stimulation
NARecruiting
132 participants
Started: Nov 6, 2024 · Completed: Dec 30, 2028
2 conditions2 sponsors1 location
NCT06358508
Sapphire 3 CTO Study
NARecruiting
170 participants
Started: Nov 6, 2024 · Completed: Dec 31, 2025
8 conditions2 sponsors14 locations
NCT06663358
A Multi-Country Observational Study of Safety and Effectiveness of Elfabrio® in Fabry Patients
N/ARecruiting
100 participants
Started: Nov 6, 2024 · Completed: Nov 30, 2029
1 condition1 sponsor1 location
NCT06989255
A Multi-center Cohort Study for Conventional Ultrasound Image Set Collection to Create a Data Set for Research Purposes.
N/ARecruiting
3,000 participants
Started: Nov 6, 2024 · Completed: Dec 31, 2025
1 condition1 sponsor5 locations
NCT06155279
Induction Chemo+Immunotherapy in Resectable Epithelioid and Biphasic Pleural Mesothelioma (CHIMERA Study)
PHASE2Recruiting
40 participants
Started: Nov 6, 2024 · Completed: Mar 31, 2027
1 condition2 sponsors8 locations
NCT06674096
RLC Followed by CR-CHOP in Elderly Patients with Newly-diagnosed DEL
PHASE2Recruiting
44 participants
Started: Nov 6, 2024 · Completed: Jun 30, 2030
1 condition1 sponsor1 location
NCT06467435
Evaluation of K9 in Subjects With Thyroid Eye Disease (TED)
PHASE1Recruiting
13 participants
Started: Nov 6, 2024 · Completed: Aug 31, 2027
1 condition2 sponsors1 location
NCT06393868
Reducing Gastrointestinal Bleeding With Proton Pump Inhibitor Therapy in Acute Venous Thromboembolism
PHASE3Recruiting
360 participants
Started: Nov 6, 2024 · Completed: Mar 31, 2028
3 conditions1 sponsor3 locations
NCT06716125
Lifestyle Changes in Obese Males With Sexual Dysfunction and Tinnitus
NARecruiting
40 participants
Started: Nov 6, 2024 · Completed: Apr 6, 2025
3 conditions1 sponsor1 location
NCT06724614
Efficacy and Safety of VDPHL01 in Males With AGA
PHASE2/PHASE3Active, not recruiting
480 participants
Started: Nov 6, 2024 · Completed: Jul 31, 2026
3 conditions1 sponsor44 locations
NCT06447987
Humanized CD19-Specific CAR T Cells for the Treatment of Patients With Positive Relapsed or Refractory CD19 Positive B-Cell Acute Lymphoblastic Leukemia
PHASE1Recruiting
24 participants
Started: Nov 6, 2024 · Completed: Dec 5, 2026
2 conditions2 sponsors1 location
NCT06664970
A Multicenter Study on the Treatment of MDS/MPN Overlap Syndrome With AZA or Rux Combined With Selinexor
PHASE2Enrolling by invitation
39 participants
Started: Nov 6, 2024 · Completed: Sep 30, 2026
1 condition1 sponsor1 location
NCT06679569
Deep Neuromuscular Blockade on Postoperative Pain
NARecruiting
106 participants
Started: Nov 6, 2024 · Completed: Nov 7, 2026
1 condition1 sponsor1 location
NCT06674473
Evaluation of Long-term Isokinetic Training of Knee Joint
NARecruiting
12 participants
Started: Nov 6, 2024 · Completed: Jul 20, 2025
1 condition2 sponsors1 location
NCT06541158
Transportation for Cancer Care Navigation Tool for Reducing Travel Barriers Among Patients With Solid Tumors Receiving Radiation Therapy
NARecruiting
76 participants
Started: Nov 6, 2024 · Completed: Feb 28, 2027
1 condition2 sponsors4 locations
NCT06784791
Preoperative Amivantamab or Amivantamab and Carboplatin/Pemetrexed Treatment in Patients With Resectable Non-small-cell Lung Cancer Harboring Oncogenic EGFR Mutations (NEOpredict-EGFR)
PHASE2Recruiting
20 participants
Started: Nov 6, 2024 · Completed: Dec 31, 2027
1 condition1 sponsor4 locations
NCT06912009
Evaluation of the Duration of Obtaining Curative Anticoagulation in Patients With Clinically Significant Pulmonary Embolism in an Intensive Care Unit
N/ARecruiting
100 participants
Started: Nov 6, 2024 · Completed: Dec 6, 2025
1 condition1 sponsor1 location
NCT06578117
Statistical Learning As a Novel Intervention for Cortical Blindness
NAEnrolling by invitation
30 participants
Started: Nov 6, 2024 · Completed: Oct 1, 2027
8 conditions1 sponsor1 location
NCT06480734
Pneumonitis in Older Lung Cancer Patients After Radiotherapy
NAActive, not recruiting
62 participants
Started: Nov 6, 2024 · Completed: Jun 30, 2026
1 condition3 sponsors5 locations
NCT06695910
Modulation of the Brain Fog Scale by Eicosapentaenoic Acid Monoglycerides (MAG-EPA).
PHASE4Recruiting
48 participants
Started: Nov 6, 2024 · Completed: Jun 1, 2026
2 conditions2 sponsors2 locations
NCT06162884
Single Time Point Prediction as Earlier Diagnosis of Progressive Pulmonary Fibrosis
N/ARecruiting
200 participants
Started: Nov 6, 2024 · Completed: Aug 19, 2028
1 condition2 sponsors1 location
NCT06806891
Restless Leg Syndrome: Is There a Response to Buddhist Walking Meditation in Hemodialysis
NARecruiting
40 participants
Started: Nov 6, 2024 · Completed: Mar 6, 2025
2 conditions1 sponsor1 location
NCT06596876
A Study to Evaluate the Efficacy and Safety of HRG2010 in Parkinson's Disease With Motor Fluctuations
PHASE3Recruiting
450 participants
Started: Nov 6, 2024 · Completed: Feb 14, 2027
1 condition1 sponsor1 location
NCT06710288
A Phase 2, Open-label, Single-arm Study Of Autologous M-CENK Adoptive Cell Therapy And N-803 (IL-15 Superagonist) In Combination With Gemcitabine In Participants With Recurrent Platinum-Resistant High-Grade Ovarian Cancer
PHASE2Recruiting
20 participants
Started: Nov 6, 2024 · Completed: May 31, 2027
1 condition1 sponsor2 locations
NCT06817525
Nab-P+Cb+PD1 Inhibitors Combined/not Combined with Bevacizumab As Neoadjuvant Therapy for Early TNBC
PHASE2Recruiting
64 participants
Started: Nov 6, 2024 · Completed: Nov 6, 2025
1 condition1 sponsor1 location
NCT06511908
Investigation of the Antidepressant Effects of (2R,6R)-HNK, an Enhancer of Synaptic Glutamate Release, in Treatment-Resistant Depression
PHASE2Recruiting
50 participants
Started: Nov 6, 2024 · Completed: Jul 1, 2027
13 conditions1 sponsor1 location
NCT06616142
Subtyping Primary Aldosteronism With Para-chloro-2-[18F]Fluoroethyl-etomidate
PHASE1/PHASE2Recruiting
12 participants
Started: Nov 6, 2024 · Completed: May 31, 2027
1 condition1 sponsor1 location